A provider of contract laboratory services and manufacturer of scientific instruments in the US, has opened a new European laboratory and office in Warwickshire, UK.
BASi, a provider of contract laboratory services and manufacturer of scientific instruments in the US, has opened a new European laboratory and office in Warwickshire, UK. The relocation to an upgraded facility with significantly expanded laboratories is expected to provide clients with enhanced capabilities throughout Europe.
The facility is reported to offer a comprehensive bioanalytical capability, as well as providing access to the company’s full range of preclinical and pharmaceutical analysis services for pharmaceutical and biotechnology companies.
"BASi Europe offers over a thousand established and validated analytical methods and procedures," said Mark Wareing, managing director of the European branch of the company. "We currently have multiple industry standard LC–MS–MS stations, as well as LC–EC and other analytical technologies, and we have invested in two more high-sensitivity MS–MS instruments with state-of-the-art front-end analytical systems."
For more information visit www.basinc.com
Extracting Estrogenic Hormones Using Rotating Disk and Modified Clays
April 14th 2025University of Caldas and University of Chile researchers extracted estrogenic hormones from wastewater samples using rotating disk sorption extraction. After extraction, the concentrated analytes were measured using liquid chromatography coupled with photodiode array detection (HPLC-PDA).
Silvia Radenkovic on Building Connections in the Scientific Community
April 11th 2025In the second part of our conversation with Silvia Radenkovic, she shares insights into her involvement in scientific organizations and offers advice for young scientists looking to engage more in scientific organizations.
Regulatory Deadlines and Supply Chain Challenges Take Center Stage in Nitrosamine Discussion
April 10th 2025During an LCGC International peer exchange, Aloka Srinivasan, Mayank Bhanti, and Amber Burch discussed the regulatory deadlines and supply chain challenges that come with nitrosamine analysis.